Results 151 to 160 of about 42,897 (306)

Opioid Prescriptions and Survival in Pancreatic Cancer [PDF]

open access: yesJCO Oncology Practice, 2022
Arjun Gupta   +2 more
openaire   +2 more sources

Emergency Department Prescription Opioids as an Initial Exposure Preceding Addiction.

open access: yes, 2016
STUDY OBJECTIVE: Opioid abuse and overdose constitute an ongoing health emergency. Many presume opioids have little potential for iatrogenic addiction when used as directed, particularly in short courses, as is typical of the emergency department (ED ...
Lyons, Michael S   +20 more
core  

Estimating the consumption of prescription opioids through wastewater analysis:The patterns of use in Italy [PDF]

open access: yes
Prescription opioids have recently experienced a diversion of use in several countries causing a huge number of overdoses due to their high potency. The aim of this study was to develop a wastewater-based epidemiology (WBE) approach to assess the use of ...
Salgueiro-Gonzalez, Noelia   +13 more
core   +1 more source

Medication prescription patterns in cancer rehabilitation physiatry outpatients: A multicenter retrospective study

open access: yesPM&R, EarlyView.
Abstract Background and Objective Previous work from this dataset found 45% prescribing frequency of any medications (35.1%, 33.5%, and 56.8% at institutions 1, 2, and 3 respectively), without significant difference between in‐person and telemedicine.
Matthew Chen   +7 more
wiley   +1 more source

Core stability in women with and without chronic pelvic pain

open access: yesPM&R, EarlyView.
Abstract Background Physical activity (PA) and core stability levels are unknown for women with musculoskeletal chronic pelvic pain (CPP) compared to healthy women. At this time, there is no validated treatment method aimed specifically at CPP. Objective To elucidate the PA habits and core stability of women with and without CPP.
Hannah V. Chatwin   +5 more
wiley   +1 more source

Proportion of Non-Medical Opioid Use of Prescription Opioids among Cancer Patients in Korea. [PDF]

open access: yesJ Hosp Palliat Care, 2023
Go SI   +5 more
europepmc   +1 more source

Intranasal diamorphine population pharmacokinetics modeling and simulation in pediatric breakthrough pain

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 435-447, March 2025.
Abstract Intranasal diamorphine (IND), approved for managing breakthrough pain in the UK, has been identified as an acceptable alternative offering effective, expedient, and less traumatic analgesia for children. However, the current dose regimen in pediatric populations relies on clinical expertise while the pharmacokinetics properties are poorly ...
Lianjin Cai   +6 more
wiley   +1 more source

Today’s nonmedical opioid users are not yesterday’s patients; implications of data indicating stable rates of nonmedical use and pain reliever use disorder

open access: yesJournal of Pain Research, 2019
Jeffrey A Singer,1–3 Jacob Z Sullum,4,5 Michael E Schatman6,7 1Valley Surgical Clinics, Ltd., Phoenix, AZ, USA; 2Department of Health Policy Studies and Center for the Study of Science, Cato Institute, Washington, DC, USA; 3Goldwater Institute ...
Singer JA, Sullum JZ, Schatman ME
doaj  

RxNorm for drug name normalization: a case study of prescription opioids in the FDA adverse events reporting system. [PDF]

open access: yesFront Bioinform, 2023
Le H   +9 more
europepmc   +1 more source

Population Pharmacokinetics and Transfer of Gabapentin When Used as a Pain Adjunct for Cesarean Deliveries

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 551-560, March 2025.
ABSTRACT Enhanced Recovery After Surgery (ERAS) protocols for cesarean deliveries (CDs) utilize multimodal pain management strategies that often include gabapentin. While gabapentin is excreted in breast milk, its pharmacokinetics in immediately postpartum lactating women are not known. This observational pharmacokinetic study (NCT05099484) enrolled 21
Rebecca Silvola   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy